Vol.
46,
No.
BIOCHEMICAL
5, 1972
AND
FRACTIONATION FROM
BIOPHYSICAL
OF OYSTER
CYSTIC
FISROSIS
I. R. Schmoyer,
CILIA
J. F. Fischer,
COMMUNICATIONS
INHIBITOR
HETEROZYGOTE
Department State University Fredonia, New
Received February
RESEARCH
SERUM
and S. P. Brooks
of Biology of New York York 14063
7, 1972 SUMMARY
A serum factor found in cystic fibrosis heterozygotes responsible for ciliary asynchrony on gills of the oyster Crassostrea virginica was prepared by ion exchange chromatography and isoelectric focusing. The cationic factor, characterized by an isoelectric point of 8.54, migrated as a single symmetrical band in acrylamide gel electrophoresis. A purified serum factor has considerable potential for detecting heterozygotes and determining the metabolic basis of the disease.
Ciliary upon
asynchrony
exposure
fibrosis
paper
to sera from
(C.F.).
existence
Speck
(I),
of a serum
reports
to heterozygote
serum.
i) investigations
factors
secretions
in many
substance
would
found
exocrine
a causative
fibrosis
This
the possible
may
or may
nature
should
as playing
a role
fibrosis
individuals
number
role in cystic
of exocrine quality.
fibrosis
Press. Inc.
Whether
be unique greatly
of this factor
been suggested
a large
This serum
not
test for heterozygotes.
but also in their
@ 1972, by Academic
parents.
convenient
of cystic
for the
in heterozygote
of this substance causative
(1,2,3) cystic
evidence
and their
which
substance
(4}.
glands
facili-
in the
in the abnormality
of
A humoral
not only
in the
or not this factor
has yet to be determined.
1923 Copyright
victims
tissues
manifesting
have presented
component
preparation
glands
secretions
of individuals
(2) and others
tissue.
of ciliated
of a more
have to affect
of their to play
have
parents
of this
A purified
concerning
in a number
to cystic
on ciliated
and ii) the development Serum
quantity
unique
on the fractionation effect
disease
heterozygotic Bowman
factor
has a distinctive
tate
has been produced
And
is indeed
BIOCHEMICAL
Vol. 46, No. 5, 1972
the existence awaits
of the factor
AND BIOPHYSICAL
in parental
serum
with
RESEARCH COMMUNICATIONS
no obvious
pathological
effects
still
explanation. The existence
developing
a
At present,
large
method
standard
clinical
changes
occuring
clinicafly
factor
to distinguish
scale detection
due to the nature
Prior
of a unique
when
tests
They ciliary
for
depend
when
on the observer’s
ability
serum
was pooled
gill method
individuals
and examined
utilizing
from
several
individuals
with
no history
of cystic
have
no ciliary
effects.
Their
procedure
was also used to assay
heterozygotes.
with active
and coworkers
fibrosis
subtle
from
for
children
ciliary
(2).
was examined
is
to most
to distinguish
from
asynchrony
This
compared
obtained
five
in
population.
is difficult.
to serum
of Bowman
instrumental
the normal
for the disease
are exposed
fibrosis
the oyster
from
prove
are elaborate
heterozygote
cystic
may
individuals
which
systems
to fractionation,
diagnosed
these
of heterozygotes
of the existing analyses.
in heterozygotes
Serum
and shown
all subsequent
to
steps
in the fractionation. The
initial
of Bowman
and coworkers
continuously standard
with buffer
Following with
step in the fractionation
five
one volume
dialysis
was dialyzed examined
0.005
of standard from against
to equilibrium for its effect
to a carboxymethyl
equilibrated
with
of standard
buffer.
buffers:
0.04
standard
M, 0.15
eluted
fractions
against
physiological
both
physiological
(CM) buffer
The
cellulose
at 3O C. The
elution
remaining
was washed
concentrated
and found
The to 3 ml. fraction
to be active
column
(1 .O x 25 cm.)
previously
column
was developed
with
was performed
using
and examined
on oyster
asynchrony
was found
1924
when
2.7 ml. of the preparation
M, and 0.5 M Tris-phosphate
Ciliary
cellulose
C.
and concentrated
of this
saline
at 0’
with
and recentrifuged.
pooled
One-tenth
gilt tissue.
was concentrated saline.
buffer.
was mixed
washed
30 minutes
minutes
were
(9 ml.)
cellulose
g., the DEAE
centrifugations
against
M, 0.25
at pH 7.2 for
for thirty
of the method
serum
(DEAE)
at 12,000 mixed
standard
Stepwise
of heterozygous
M Tris-HCl
buffer,
on oyster
was applied
was a modification
of diethylaminoethyl
of centrifugation
fractions
by vacuum
One volume
volumes
containing
10 minutes
supernatant
(5).
sequence
30 ml.
30 ml. of each of the following at pH 7.5. gill tissue only
upon
Each of the
following application
dialysis of
Vol.
46,Noc5,1972
the 0.04
BIOCHEMICAL
M elutant.
(LKB-Produkter
This fraction AB)
Isoelectric column
(LKB).
of protein
in preparation
focusing
for
was carried
sucrose
as a stabilizing
midway
was applied
followed
by 12 hours
pH was noted
from
absorbance
at 280 mu.
only
the fractions
asynchrony
activity.
one-fourth
the time
these fractions which
(3-7
contained contained
was prepared
The dialyzed
sample
of Lowry
24 hours.
Fifty
against
produced
seen for heterozygous
serum
only
l-2 mg./ml.
as compared
60-70
mg./ml.
increased
to 600 V were
was estimated
found ciliary
min.)
of protein
was of 300 V
physiological
1, Peak II) were
fractions
(6).
2 ml. fractions content
(17-20
from
5.6 mg.
potential
was then
and the protein
8 to 9 (Figure
containing
An initial
at 900 V.
dialysis
series ampholyte
and coworkers
The voltage
vacuum
focused
ampholyte
for a pH range
of focusing
Isoelectrically
carrier
focusing.
of the gradient.
Following
1% light
gradient
for each sample
in the pH range
against
COMMUNICATIONS
8100
matrix.
C for
RESEARCH
in a 110 ml. capacity,
by the method
at 3’
The
dialyzed
out
the preparation
to the column
for 24 hours collected.
through
BIOPHYSICAL
isoelectric
stepwise
in 1 ml., as determined
applied
serum
was then
A discontinuous,
3 to 10 using
AND
saline
to have ciliary asynchrony
min.).
in
Moreover,
to active
heterozygous
of protein.
II IO 9 e 7: 6 s 4 3
Tube
Numbrr
Figure 1. Isoelectric focusing at pH 3-10 of the CM cellulose and broken lines represent absorbance and pH, respectively.
Acrylamide
gel electrophoresis
and all of the active Davis
(8).
Two
fractions
hundred
using
micrograms
at pH 8.9 was performed a modification of heterozygous
1925
active
Solid
on heterozygous
of the procedures serum
fraction.
of Clark
and lesser amounts
serum (7) and of
Vol.46,No.5,
1972
subsequent
fractions
to migrate tion
for
resulted
active
BIOCHEMICAL
were
applied
25 minutes
geneous
profile
focusing
on a shallow
active
peaks
units,
migrated
a single
of heterozygous
(9).
elution
in the number
displayed
symmetrical serum
peaks,
to identical
RESEARCH
with
bands. This
2).
However,
resulted
The
in acrylamide
isoelectrically
is contrasted we found
in isoionic
and allowed
Each step in the fractiona-
in the resolution
differences
positions
dye.
band.
(Figure
COMMUNICATIONS
gels, respectively,
of the tracker of observed
7-9 pH gradient
These
BIOPHYSICAL
to 7 and 5% acrylamide
following
in a decrease
fraction
AND
with
the hetero-
that
isoelectric
of at least
points
focused
two
of less then
separate 0.3 pH
gels.
: I-I b
a
Figure 2. Absorption profiles at 540 mu of amido shwarz stained acrylamide electrophoresis gels of a) heterozygous serum (5% gel) and b) active fraction pH 3-10 isoelectric focusing column (7% gel).
The resolution focusing after
is interesting
elution
of these
in light
of homozygous
of 60,000
of a number
This work
of Speck’s
weight (1).
New
York
University
of New
York
(GR
of active
finding.
He discovered
a Sephadex
of at least
200,000
Therefore,
of larger
a number
from
molecular
was supported
of Western
into
serum
had a molecular
on the order subunit
of the factor
(024-7137A).
G-200
with two
isoelectric active
gel filtration
and the smaller
the possibility
exists
that
fractions column.
a molecular the factor
One weight
may
be a
complexes.
by research
36FRE71)
peaks
disc from the
grants
and The
from
Research
J. F. Fischer
1926
the United Foundation
was supported
Health
Foundations
of The State in part
by a United
Vol.
46, No.
5, 1972
Health
Foundation
his valuable for their
BIOCHEMICAL
Fellowship
assistance technical
in obtaining
AND
BIOPHYSICAL
(PFT-64-Fre-71). blood
The authors
specimens
and Diane
RESEARCH
thank Pennica
COMMUNICATIONS
Dr. J. Forbes and
Karen
for 0:Keefe
assistance.
References 1. 2. 3. 4.
5. 6. 7. 8. 9.
A. Speck, H.M.C. Heick, H. Cress, W.S. Logan, Pediat. Res. 3 173 (1967). B.H. Bowman, L.H. Lockhart, M.L. McCombs, sew, 325 (1969). G.T.N. Besley. A.D. Patrick, A.P. Norman,& Med. Genet. 4 278 (1969). A. Speck in Cystic Fibrosis and Related HumaGdzal Diseases: Symposium Highlights, S. Jakowska, Conference Ed., (Gordon and Breach, New York, 1970), p. 70. B.H. Bowman, M.L. McCombs, L.H. Lockhart, Science 167,871 (1970). O.H. Lowry, N.J. Rosenbrough, A.L. Farr, R.J. Randall, J. Biol. Chem. 193 -m---1 265 11951). J.T. Clarke 8&Ann N-‘-‘-‘-‘-* Y Acad SC 121 428 (1964). B.J. Davis, --8 ibid. 121 428 (1964). I.R. Schmoyer, S.P. Brooks, J.F. Fischer, in preparation.
1927